Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

AQST

Aquestive Therapeutics (AQST)

Aquestive Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AQST
DateTimeSourceHeadlineSymbolCompany
20/02/202523:00GlobeNewswire Inc.Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
15/02/202510:12Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
12/02/202523:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
12/02/202523:00GlobeNewswire Inc.Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual MeetingNASDAQ:AQSTAquestive Therapeutics Inc
04/02/202523:00GlobeNewswire Inc.Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare ConferenceNASDAQ:AQSTAquestive Therapeutics Inc
25/01/202508:51Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AQSTAquestive Therapeutics Inc
13/01/202523:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
13/01/202523:00GlobeNewswire Inc.Aquestive Therapeutics Provides Business Update and Outlines Key 2025 ObjectivesNASDAQ:AQSTAquestive Therapeutics Inc
20/12/202400:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
20/12/202400:00GlobeNewswire Inc.Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to FiveNASDAQ:AQSTAquestive Therapeutics Inc
03/12/202400:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
03/12/202400:00GlobeNewswire Inc.Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual FilmNASDAQ:AQSTAquestive Therapeutics Inc
28/11/202408:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
15/11/202407:47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
13/11/202400:00GlobeNewswire Inc.Aquestive Therapeutics to Participate in Two Upcoming Investor ConferencesNASDAQ:AQSTAquestive Therapeutics Inc
09/11/202409:31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AQSTAquestive Therapeutics Inc
08/11/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
07/11/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
05/11/202408:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
05/11/202408:36GlobeNewswire Inc.Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AQSTAquestive Therapeutics Inc
25/10/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
25/10/202423:00GlobeNewswire Inc.Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American CollegeNASDAQ:AQSTAquestive Therapeutics Inc
24/10/202423:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
24/10/202423:00GlobeNewswire Inc.Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual FilmNASDAQ:AQSTAquestive Therapeutics Inc
23/10/202409:06Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AQSTAquestive Therapeutics Inc
21/10/202423:00GlobeNewswire Inc.Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
17/10/202408:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
03/10/202404:16Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
03/10/202404:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
03/10/202404:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AQSTAquestive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AQST

Your Recent History

Delayed Upgrade Clock